The global Drug And Gene Delivery Systems Market is expected to reach USD 786.9 Billion by 2025, according to a new report by Grand View Research, Inc. Rising investment by the market players to develop innovative drug delivery systems to cater to the demand by the patients as well as to increase the bioavailability at minimum quantity of active pharmaceutical ingredient is driving the market growth. Additionally, increasing focus on R&D of gene delivery systems owing to the high growth potential of gene therapy for the treatment of a wide range of diseases is expected to fuel the market growth in the future.
Drug delivery systems are in a constant evolution along with the changing preference by the patient. For instance, initially, hormone replacement therapy was widely prescribed in the form of pills, whereas, it is now available in the form of prefilled syringes, patches, vaginal rings, gel, and sprays. The principal purpose of development of different forms of delivery systems is to increase the ease of use. Factors such as aesthetics of the delivery systems, price, and amount of API are also considered while designing the drug delivery system.
Japan drug delivery systems market, by route of administration, 2014 – 2025 (USD Billion)
Request a Sample Copy of the Global Drug And Gene Delivery Systems Market Research Report @ https://www.grandviewresearch.com/industry-analysis/drug-gene-delivery-devices-market/request/rs1
Further key findings from the study suggest:
Global gene delivery systems market, by vector, 2015 (%)
Have Any Query? Ask Our Experts @ https://www.grandviewresearch.com/inquiry/3463/ibb
Grand View Research has segmented the drug and gene delivery systems market on the basis of route of administration, vectors, methods, and region:
Route of Administration Outlook (Revenue, USD Billion, 2014 – 2025)
Vector Outlook (Revenue, USD Million, 2014 – 2025)
Method Outlook (Revenue, USD Million, 2014 – 2025)
Regional Outlook (Revenue, USD Billion, 2014 – 2025)
Browse Related Category @
Antidiabetics Market: Growing worldwide prevalence of diabetes (both type I and type II) is expected to be a key driver for insulin and oral hypoglycemic drugs demand.
Contraceptives Market: The global contraceptives market is estimated to grow at a lucrative rate over the forecast period owing to, increasing the prevalence of sexually transmitted diseases and growing need for population control
About Grand View Research
Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S.-based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.
Media ContactCompany Name: Grand View Research, Inc.Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.Email: Send EmailPhone: 1-415-349-0058, Toll Free: 1-888-202-9519Address:201, Spear Street, 1100 City: San FranciscoState: CaliforniaCountry: United StatesWebsite: www.grandviewresearch.com/industry-analysis/drug-gene-delivery-devices-market